alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Carcinoma, Renal Cell in 1 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer and has the highest propensity to manifest as metastatic disease." | 1.40 | Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4. ( Anastasiadis, PZ; Cooper, SJ; Copland, JA; Grebe, SK; Marlow, LA; Radisky, DC; Tun, HW; von Roemeling, CA, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| von Roemeling, CA | 1 |
| Radisky, DC | 1 |
| Marlow, LA | 1 |
| Cooper, SJ | 1 |
| Grebe, SK | 1 |
| Anastasiadis, PZ | 1 |
| Tun, HW | 1 |
| Copland, JA | 1 |
1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; C-Reactive Protein; Carcinoma, Renal Cell; | 2014 |